Comparison of Field-in-Field Radiotherapy with Conformal Radiotherapy for Unilateral Cervical Malignant Lymphoma

被引:0
作者
Yamashita, Mako [1 ,2 ]
Katayama, Norihisa [2 ]
Waki, Takahiro [2 ]
Katsui, Kuniaki [2 ]
Himei, Kengo [3 ]
Takemoto, Mitsuhiro [4 ]
Kanazawa, Susumu [2 ]
机构
[1] Nippon Kokan Fukuyama Hosp, Dept Radiol, Fukuyama, Hiroshima 7210927, Japan
[2] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Radiol, Okayama 7008558, Japan
[3] Japanese Red Cross Okayama Hosp, Dept Radiol, Okayama 7008607, Japan
[4] Himeji Hosp, Japanese Red Cross Soc, Dept Radiol, Himeji, Hyogo 6708540, Japan
关键词
field-in-field technique; wedge; lymphoma; monitor units; dose-volume histogram; INVOLVED-FIELD; RADIATION-THERAPY; DISEASE; RISK; CHEMOTHERAPY; HEAD;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
This study compared field-in-field (FIF) radiotherapy with conformal radiotherapy with physical wedges for the treatment of unilateral cervical malignant lymphoma. Two treatment plans, the FIF technique and conformal RT, were generated for each of 32 patients with unilateral cervical malignant lymphoma. To compare the 2 treatment plans, dose-volume histograms of the planning target volume (PTV), the thyroid, submandibular gland, carotid artery, mucosa, spinal cord, and surrounding normal tissue, and monitor unit (MU) were analyzed. The FIF technique showed significant reduction in the mean dose of thyroid, submandibular gland, carotid artery and mucosa, the maximum dose of the spinal cord and PTV, and the volume receiving > 107% of the prescribed dose of surrounding normal tissue (p < 0.001). In addition, there were gains in the homogeneity index of the PTV for FIF. Furthermore, the total MU was also lower for the FIF technique than for the wedge technique (p < 0.001). Compared with the wedge technique, the FIF technique improved the dose homogeneity of the PTV, reduced the dose to normal structures, and was associated with fewer MUs in the treatment of patients with cervical malignant lymphoma.
引用
收藏
页码:189 / 195
页数:7
相关论文
共 23 条
[1]   ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: Long-term results [J].
Bonadonna, G ;
Bonfante, V ;
Viviani, S ;
Di Russo, A ;
Villani, F ;
Valagussa, P .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :2835-2841
[2]   CLINICOPATHOLOGICAL FEATURES AND PROGNOSTIC FACTORS IN EXTRANODAL NON-HODGKIN LYMPHOMAS [J].
DAMORE, F ;
CHRISTENSEN, BE ;
BRINCKER, H ;
PEDERSEN, NT ;
THORLING, K ;
HASTRUP, J ;
PEDERSEN, M ;
JENSEN, MK ;
JOHANSEN, P ;
ANDERSEN, E ;
BACH, B ;
SORENSEN, E .
EUROPEAN JOURNAL OF CANCER, 1991, 27 (10) :1201-1208
[3]   Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer [J].
Darby, Sarah C. ;
Ewertz, Marianne ;
McGale, Paul ;
Bennet, Anna M. ;
Blom-Goldman, Ulla ;
Bronnum, Dorthe ;
Correa, Candace ;
Cutter, David ;
Gagliardi, Giovanna ;
Gigante, Bruna ;
Jensen, Maj-Britt ;
Nisbet, Andrew ;
Peto, Richard ;
Rahimi, Kazem ;
Taylor, Carolyn ;
Hall, Per .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (11) :987-998
[4]   Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].
Eichenauer, D. A. ;
Engert, A. ;
Dreyling, M. .
ANNALS OF ONCOLOGY, 2011, 22 :vi55-vi58
[5]  
Elerding SC, 1999, RADIOLOGY, V213, P167
[6]   Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma:: Results of the HD8 trial of the German Hodgkin's Lymphoma Study Group [J].
Engert, A ;
Schiller, P ;
Josting, A ;
Herrmann, R ;
Koch, P ;
Sieber, M ;
Boissevain, F ;
de Wit, M ;
Mezger, J ;
Dühmke, E ;
Willich, N ;
Müller, RP ;
Schmidt, BF ;
Renner, H ;
Müller-Hermelink, HK ;
Pfistner, B ;
Wolf, J ;
Hasenclever, D ;
Löffler, M ;
Diehl, V .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (19) :3601-3608
[7]   Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease [J].
Ferme, Christophe ;
Eghbali, Houchingue ;
Meerwaldt, Jacobus H. ;
Rieux, Chantal ;
Bosq, Jacques ;
Berger, Francoise ;
Girinsky, Theodore ;
Brice, Pauline ;
van't Veer, Mars B. ;
Walewski, Jan A. ;
Lederlin, Pierre ;
Tirelli, Umberto ;
Carde, Patrice ;
Van den Neste, Eric ;
Gyan, Emmanuel ;
Monconduit, Mathieu ;
Divine, Marine ;
Raemaekers, John M. M. ;
Salles, Gilles ;
Noordijk, Evert M. ;
Creemers, Geert-Jan ;
Gabarre, Jean ;
Hagenbeek, Anton ;
Reman, Oumedaly ;
Blanc, Michel ;
Thomas, Jose ;
Vie, Brigitte ;
Kluin-Nelemans, Johanna C. ;
Viseu, Fernando ;
Baars, Joke W. ;
Poortmans, Philip ;
Lugtenburg, Pieternella J. ;
Carrie, Christian ;
Jaubert, Jerome ;
Henry-Amar, Michel .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (19) :1916-1927
[8]  
Gospodarowicz, 1995, Semin Radiat Oncol, V5, P281, DOI 10.1016/S1053-4296(05)80027-X
[9]   Intensity-modulated radiation therapy, protons, and the risk of second cancers [J].
Hall, Eric J. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (01) :1-7
[10]   NCCN Clinical Practice Guidelines in Oncology for Hodgkin Lymphoma [J].
Hoppe, Richard T. ;
Advani, Ranjana H. ;
Ai, Weiyun Z. ;
Ambinder, Richard F. ;
Bello, Celeste M. ;
Bierman, Philip J. ;
Blum, Kristie A. ;
Dabaja, Bouthaina ;
Duron, Ysabel ;
Forero, Andres ;
Gordon, Leo I. ;
Hernandez-Ilizaliturri, Francisco J. ;
Hochberg, Ephraim P. ;
Maloney, David G. ;
Mansur, David ;
Mauch, Peter M. ;
Metzger, Monika ;
Moore, Joseph O. ;
Morgan, David ;
Moskowitz, Craig H. ;
Poppe, Matthew ;
Pro, Barbara ;
Weiss, Lawrence ;
Winter, Jane N. ;
Yahalom, Joachim .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2011, 9 (09) :1020-1058